BioCentury
ARTICLE | Company News

Amorfix, JSW Lifesciences GmbH deal

June 18, 2012 7:00 AM UTC

CRO JSW Lifesciences received an exclusive, worldwide license to market and to use as a service Amorfix's Amorfix Aggregated Abeta Assay (A4) for preclinical research in Alzheimer's disease (AD). Amor...